Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma.

Lee SR, Kim HO, Son BH, Yoo CH, Shin JH.

Hepatogastroenterology. 2013 Mar-Apr;60(122):358-62. doi: 10.5754/hge12727.

PMID:
23574658
2.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
3.

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.

Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.

PMID:
18376190
4.

Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.

Partelli S, Crippa S, Barugola G, Tamburrino D, Capelli P, D'Onofrio M, Pederzoli P, Falconi M.

Ann Surg Oncol. 2011 Dec;18(13):3608-14. doi: 10.1245/s10434-011-1769-1. Epub 2011 May 17.

PMID:
21584836
5.

A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.

Kim R, Tsao R, Tan A, Byrne M, Almhanna K, Lazaryan A, Elson P, Pelley RJ.

J Gastrointest Surg. 2010 Jul;14(7):1159-69. doi: 10.1007/s11605-010-1213-z. Epub 2010 May 6.

PMID:
20446118
6.

The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.

Ozaki H, Hiraoka T, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T, Tsunoda T, Suzuki T, Monden M, Saitoh Y, Yamauchi H, Ogata Y.

Surg Today. 1999;29(1):16-22.

PMID:
9934826
7.

Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.

Strobel O, Hartwig W, Hackert T, Hinz U, Berens V, Grenacher L, Bergmann F, Debus J, Jäger D, Büchler M, Werner J.

Ann Surg Oncol. 2013 Mar;20(3):964-72. doi: 10.1245/s10434-012-2762-z. Epub 2012 Dec 12.

PMID:
23233235
8.

Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.

You DD, Lee HG, Heo JS, Choi SH, Choi DW.

J Gastrointest Surg. 2009 Sep;13(9):1699-706. doi: 10.1007/s11605-009-0969-5. Epub 2009 Jul 7.

PMID:
19582512
9.

Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.

Kimura K, Amano R, Nakata B, Yamazoe S, Hirata K, Murata A, Miura K, Nishio K, Hirakawa T, Ohira M, Hirakawa K.

World J Surg Oncol. 2014 Nov 27;12:360. doi: 10.1186/1477-7819-12-360.

10.

[Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].

Soriano-Izquierdo A, Adet AC, Gallego R, Miquel R, Castells A, Pellisé M, Nadal C, López-Boado MA, Piqué JM, Gascón P, Conill C, Bombí A, Fernández-Cruz L, Maurel J, Navarro S.

Med Clin (Barc). 2009 Feb 14;132(5):163-71. doi: 10.1016/j.medcli.2008.07.012. Epub 2009 Feb 7. Spanish.

PMID:
19211081
11.

Significance of pathologic response to preoperative therapy in pancreatic cancer.

Chun YS, Cooper HS, Cohen SJ, Konski A, Burtness B, Denlinger CS, Astsaturov I, Hall MJ, Hoffman JP.

Ann Surg Oncol. 2011 Dec;18(13):3601-7. doi: 10.1245/s10434-011-2086-4. Epub 2011 Sep 27.

PMID:
21947697
12.

Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.

Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S.

J Am Coll Surg. 2004 May;198(5):722-31.

PMID:
15110805
13.

Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.

Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA.

Eur J Surg Oncol. 2012 Apr;38(4):333-9. doi: 10.1016/j.ejso.2011.12.020. Epub 2012 Feb 7.

PMID:
22317758
14.

The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.

Luna-Pérez P, Reyna Huelga A, Labastida Almendaro S, Rodríguez-Coria DF, González Macouzet J, Delgado Gallardo S.

Rev Invest Clin. 1999 Jul-Aug;51(4):205-13.

PMID:
10546501
15.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

16.

Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.

Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, Busch OR, van Gulik TM, Obertop H, Gouma DJ.

Eur J Cancer. 2004 Mar;40(4):549-58.

PMID:
14962722
18.

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.

Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, Schurr PG, Liebl L, Thieltges S, Gawad KA, Schneider C, Izbicki JR.

Ann Surg. 2008 Feb;247(2):300-9. doi: 10.1097/SLA.0b013e31815aab22.

PMID:
18216537
19.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881
20.

Does preoperative biliary drainage compromise the long-term survival of patients with pancreatic head carcinoma?

Murakami Y, Uemura K, Hashimoto Y, Kondo N, Nakagawa N, Sasaki H, Hatano N, Kohmo T, Sueda T.

J Surg Oncol. 2015 Mar;111(3):270-6. doi: 10.1002/jso.23797. Epub 2014 Sep 29.

PMID:
25266938

Supplemental Content

Support Center